BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25304610)

  • 21. Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
    Spinelli O; Peruta B; Tosi M; Guerini V; Salvi A; Zanotti MC; Oldani E; Grassi A; Intermesoli T; Micò C; Rossi G; Fabris P; Lambertenghi-Deliliers G; Angelucci E; Barbui T; Bassan R; Rambaldi A
    Haematologica; 2007 May; 92(5):612-8. PubMed ID: 17488684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.
    Furness CL; Mansur MB; Weston VJ; Ermini L; van Delft FW; Jenkinson S; Gale R; Harrison CJ; Pombo-de-Oliveira MS; Sanchez-Martin M; Ferrando AA; Kearns P; Titley I; Ford AM; Potter NE; Greaves M
    Leukemia; 2018 Sep; 32(9):1984-1993. PubMed ID: 29556024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
    Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
    J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia.
    Astolfi A; Vendemini F; Urbini M; Melchionda F; Masetti R; Franzoni M; Libri V; Serravalle S; Togni M; Paone G; Montemurro L; Bressanin D; Chiarini F; Martelli AM; Tonelli R; Pession A
    Oncotarget; 2014 Jan; 5(1):120-30. PubMed ID: 24334727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells.
    Cardoso BA; de Almeida SF; Laranjeira AB; Carmo-Fonseca M; Yunes JA; Coffer PJ; Barata JT
    Leukemia; 2011 Oct; 25(10):1578-86. PubMed ID: 21647153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infrequent erythrophagocytosis by leukemic blasts in de novo T-lymphoblastic leukemia with SIL-TAL1: A rare pediatric case.
    Li T; Su L; Li X; Zhang Y; Li L; Zhu J
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30544. PubMed ID: 37407425
    [No Abstract]   [Full Text] [Related]  

  • 28. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
    Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G
    Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RT/PCR detection of SIL-TAL-1 fusion mRNA in Chinese T-cell acute lymphoblastic leukemia (T-ALL).
    Huang W; Kuang SQ; Huang QH; Dong S; Zhang T; Gu LJ; Ching LM; Chen SJ; Chang LC; Chen Z
    Cancer Genet Cytogenet; 1995 May; 81(1):76-82. PubMed ID: 7773964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SIL/TAL1 recombination in adult T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma.
    Kwong YL; Chan D; Liang R
    Cancer Genet Cytogenet; 1995 Dec; 85(2):159-60. PubMed ID: 8548743
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study.
    Bash RO; Crist WM; Shuster JJ; Link MP; Amylon M; Pullen J; Carroll AJ; Buchanan GR; Smith RG; Baer R
    Blood; 1993 Apr; 81(8):2110-7. PubMed ID: 8471769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia].
    Chai YH; Lü H; Li JQ; Lu J; Xiao PF; He YX; Shao XJ
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):684-6. PubMed ID: 18021563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.
    Smith C; Goyal A; Weichenhan D; Allemand E; Mayakonda A; Toprak U; Riedel A; Balducci E; Manojkumar M; Pejkovska A; Mücke O; Sollier E; Bakr A; Breuer K; Lutsik P; Hermine O; Spicuglia S; Asnafi V; Plass C; Touzart A
    Haematologica; 2023 May; 108(5):1259-1271. PubMed ID: 36632736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T-acute lymphoblastic leukemia: long-term comparison of outcomes in the JACLS NHL T-98 and ALL T-97 protocols.
    Kobayashi R; Takimoto T; Nakazawa A; Fujita N; Akazai A; Yamato K; Yazaki M; Deguchi T; Hashii Y; Kato K; Hatakeyama N; Horibe K; Hori H; Oda M;
    Int J Hematol; 2014 Jun; 99(6):743-9. PubMed ID: 24803201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel translocation t(1;5)(p32;q31) that was not associated with the TAL1 rearrangement in a case of T lymphoblastic leukemia/lymphoma.
    Cho HS; Kim MK; Bae YK
    Korean J Lab Med; 2009 Jun; 29(3):199-203. PubMed ID: 19571616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis.
    Ballerini P; Blaise A; Busson-Le Coniat M; Su XY; Zucman-Rossi J; Adam M; van den Akker J; Perot C; Pellegrino B; Landman-Parker J; Douay L; Berger R; Bernard OA
    Blood; 2002 Aug; 100(3):991-7. PubMed ID: 12130513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
    Noura M; Matsuo H; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
    Oncogene; 2024 Feb; 43(6):447-456. PubMed ID: 38102337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous rearrangements of TAL1 and LMO2 in T-cell acute lymphoblastic leukemia.
    Kim HK; Lim JH; Koh KN; Chi HS; Seo EJ
    Int J Lab Hematol; 2014 Oct; 36(5):e69-70. PubMed ID: 24330618
    [No Abstract]   [Full Text] [Related]  

  • 39. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
    Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
    McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
    Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.